Just a brief note to point out that the clinicaltrials site has been updated (28 Oct) to reflect the situation as set out in recent anns.
The FXS trial declared finished in October. The TBI trial declared as finished recruiting but ongoing, due to finish Jan 2016.
No surprises there.
The only thing I'm drawing from this is that, given they were updating the information, the concussion trial is still as it was updated on 8 Oct, with a completion date listed for June 2016.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren completes enrolment in INTREPID clinical trial
Ann: Neuren completes enrolment in INTREPID clinical trial, page-8
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
Add NEU (ASX) to my watchlist
|
|||||
Last
$18.65 |
Change
-0.540(2.81%) |
Mkt cap ! $2.383B |
Open | High | Low | Value | Volume |
$18.98 | $19.15 | $18.50 | $10.51M | 560.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | $18.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.65 | 1127 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 18.530 |
4 | 1225 | 18.510 |
7 | 2678 | 18.500 |
2 | 1169 | 18.490 |
1 | 162 | 18.450 |
Price($) | Vol. | No. |
---|---|---|
19.080 | 300 | 1 |
19.150 | 150 | 1 |
19.200 | 899 | 2 |
19.240 | 550 | 1 |
19.340 | 1000 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
NEU (ASX) Chart |